The kill-switch for CRISPR that could make gene-editing safer
Elie Dolgin • January 15, 2020
How anti-CRISPR proteins and other molecules could bolster biosecurity and improve medical treatments.
It started out as “sort of a stupid thing to do”, recalls Joe Bondy-Denomy, a microbiologist at the University of California, San Francisco.
Continue reading here.
Circulating biomarkers are quickly becoming a crucial part of diagnosis and disease monitoring for physicians, researchers — and even some consumers.
Zebras and giraffes offer one another protection without food competition.